<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1≥50%) of LABAs compared with placebo.</p
<p>Meta-analysis of transfusion rate on IV-TXA versus combined TXA administration.</p
<p>Meta-analysis of the risk ratios of overall response rate comparing bevacizumab and standard ther...
<p>The analyses of acute coronary syndrome risk included data from acute coronary syndrome, acute my...
<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1<50%) of LABAs compared with placebo.</...
<p>Meta-analysis of fatal cardiovascular events in RCTs of LABAs compare with placebo.</p
<p>Meta-analysis of fatal cardiovascular events in short-term RCTs of LABAs compared with placebo.</...
<p>Meta-analysis of fatal cardiovascular events in long-term RCTs of LABAs compared with placebo.</p
<p>Abbreviations: CI, confidence interval; RCT, randomized controlled trials; RR, relative risk</p><...
<p>Meta-analysis of the logs hazard ratios of overall survival comparing bevacizumab and standard th...
<p><b>F:</b> fatal; <b>MCCE:</b> Major cardiovascular and cerebrovascular events; <b>MI:</b> myocard...
<p>Meta-analysis of fatal CVD events in populations with varying degrees of control for CVD status a...
<p>Meta-analysis of the log hazard ratios of progression free survival comparing bevacizumab and sta...
<p>Meta-analysis of all trials comparing clopidogrel plus aspirin with aspirin plus placebo or aspir...
<p>Imputed placebo analysis. Comparison of new oral anticoagulants versus imputed placebo on the ris...
<p>Imputed placebo analysis. Comparison of new oral anticoagulants versus imputed placebo on the ris...
<p>Meta-analysis of transfusion rate on IV-TXA versus combined TXA administration.</p
<p>Meta-analysis of the risk ratios of overall response rate comparing bevacizumab and standard ther...
<p>The analyses of acute coronary syndrome risk included data from acute coronary syndrome, acute my...
<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1<50%) of LABAs compared with placebo.</...
<p>Meta-analysis of fatal cardiovascular events in RCTs of LABAs compare with placebo.</p
<p>Meta-analysis of fatal cardiovascular events in short-term RCTs of LABAs compared with placebo.</...
<p>Meta-analysis of fatal cardiovascular events in long-term RCTs of LABAs compared with placebo.</p
<p>Abbreviations: CI, confidence interval; RCT, randomized controlled trials; RR, relative risk</p><...
<p>Meta-analysis of the logs hazard ratios of overall survival comparing bevacizumab and standard th...
<p><b>F:</b> fatal; <b>MCCE:</b> Major cardiovascular and cerebrovascular events; <b>MI:</b> myocard...
<p>Meta-analysis of fatal CVD events in populations with varying degrees of control for CVD status a...
<p>Meta-analysis of the log hazard ratios of progression free survival comparing bevacizumab and sta...
<p>Meta-analysis of all trials comparing clopidogrel plus aspirin with aspirin plus placebo or aspir...
<p>Imputed placebo analysis. Comparison of new oral anticoagulants versus imputed placebo on the ris...
<p>Imputed placebo analysis. Comparison of new oral anticoagulants versus imputed placebo on the ris...
<p>Meta-analysis of transfusion rate on IV-TXA versus combined TXA administration.</p
<p>Meta-analysis of the risk ratios of overall response rate comparing bevacizumab and standard ther...
<p>The analyses of acute coronary syndrome risk included data from acute coronary syndrome, acute my...
DOI
Add to ORKG